Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
US6307089A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Dec 14, 2000 |
| Grant date | Oct 23, 2001 |
| Priority date | — |
| Expiry date | Dec 14, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C255/64
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Biphenyl butyric acid compounds and derivatives are described as well as acid methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A (72 kD gelatinase) and stromelysin-1 and for the treatment of multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer, inflammation, pain, arthritis, or other autoimmune or inflammatory disorders dependent upon tissue invasion by leukocytes or other activated migrating cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.